$59.66 +0.28 (%) Merck & Co Inc - NYSE

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. You Should Hold Merck According to Dividends Generation

    GuruFocus | Nov. 21, 2014 | 13:47PM EST
  2. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  3. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  4. Merck's Vytorin Works: Study

    IBD | Nov. 17, 2014 | 18:39PM EST
  5. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  6. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  7. Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At American Heart Association Scientific Sessions Today

    Benzinga | Nov. 17, 2014 | 08:31AM EST
  8. Gilead Sciences Releases Impressive Results for Hepatitis C Drug

    GuruFocus | Nov. 12, 2014 | 11:56AM EST
  9. Stocks Chart Out Narrow Losses; Vodafone Group Leads Nasdaq 100

    IBD | Nov. 11, 2014 | 10:29AM EST
  10. Merck down on hep C data

    IBD | Nov. 10, 2014 | 19:00PM EST
  11. Merck Shares May Have Hit A Ceiling For The Most Recent Upside Move

    Benzinga | Nov. 10, 2014 | 17:32PM EST
  12. Stock Movers: Why These 5 Top Stocks Are Rising Today

    IBD | Nov. 10, 2014 | 14:04PM EST
  13. Merck Down On Hepatitis C Data; Gilead Rises

    IBD | Nov. 10, 2014 | 11:14AM EST
  14. RBC Sees Weak Merck Data As Positive For Gilead

    Benzinga | Nov. 10, 2014 | 09:29AM EST
  15. Premarket: Stock Futures Mixed; Gilead Climbs On Merck News

    IBD | Nov. 10, 2014 | 08:59AM EST
  16. A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio

    GuruFocus | Nov. 9, 2014 | 18:16PM EST
  17. Kahn Brothers' Third Quarter Numbers

    GuruFocus | Nov. 7, 2014 | 17:43PM EST
  18. Stock Futures Shed Losses, Rise; Sierra Wireless, Tableau Rocket

    IBD | Nov. 6, 2014 | 08:58AM EST
  19. US Stock Futures Edge Lower Ahead Of Earnings, Jobless Claims

    Benzinga | Nov. 6, 2014 | 07:47AM EST
  20. Veeva Systems Flies High On Cloud For Life Sciences

    IBD | Oct. 30, 2014 | 17:31PM EST
  21. Bristol-Myers Lung-Cancer Drug Boosts Survival

    IBD | Oct. 30, 2014 | 11:31AM EST
  22. Dividend Aristocrats In Focus Parts 30: Sigma-Aldrich

    GuruFocus | Oct. 28, 2014 | 15:17PM EST
  23. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD | Oct. 28, 2014 | 14:42PM EST
  24. Video: Facebook, Gilead Post Earnings After The Close

    IBD | Oct. 28, 2014 | 14:00PM EST
  25. Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics

    Benzinga | Oct. 27, 2014 | 20:18PM EST
  26. Merck sales fall, miss views

    IBD | Oct. 27, 2014 | 18:55PM EST
  27. Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook

    Benzinga | Oct. 27, 2014 | 16:58PM EST
  28. Gilead Rises Ahead Of Q3 Earnings As Rivals Wobble

    IBD | Oct. 27, 2014 | 15:38PM EST
  29. Merck Conference Call Highlights

    Benzinga | Oct. 27, 2014 | 15:34PM EST
  30. Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide

    Benzinga | Oct. 27, 2014 | 15:15PM EST
  31. Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip

    Benzinga | Oct. 27, 2014 | 12:41PM EST
  32. Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings

    Benzinga | Oct. 27, 2014 | 11:12AM EST
  33. Stock Futures Point Lower; Brazil Vote Hammers Petrobras

    IBD | Oct. 27, 2014 | 09:05AM EST
  34. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations

    Benzinga | Oct. 27, 2014 | 08:19AM EST
  35. US Stock Futures Down Ahead Of Economic Data

    Benzinga | Oct. 27, 2014 | 07:35AM EST
  36. Earnings Scheduled For October 27, 2014

    Benzinga | Oct. 27, 2014 | 05:06AM EST
  37. Keep an Eye on These 7 Stocks for October 27, 2014

    Benzinga | Oct. 27, 2014 | 04:21AM EST
  38. Earnings Expectations For The Week Of October 27: Facebook, Exxon, Pfizer And Much More

    Benzinga | Oct. 26, 2014 | 16:55PM EST
  39. Stocks Put End To Four-Week Slide

    IBD | Oct. 24, 2014 | 16:56PM EST
  40. Fast Money Halftime Report Final Trade From October 24

    Benzinga | Oct. 24, 2014 | 16:50PM EST
  41. Bristol-Myers Beats Q3 Views As Eliquis Revives

    IBD | Oct. 24, 2014 | 13:23PM EST
  42. Fast Money Picks For October 23

    Benzinga | Oct. 23, 2014 | 07:00AM EST
  43. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  44. Gilead's Hep C Dream Drug Faces Demanding Investors

    IBD | Oct. 22, 2014 | 16:44PM EST
  45. What is Abner Herrman Investing In?

    GuruFocus | Oct. 16, 2014 | 15:59PM EST
  46. Will Activis Win Competition For Allergan's Affection?

    Benzinga | Oct. 16, 2014 | 11:10AM EST
  47. IPO Calendar: Biotech Companies Lead List Of 7 IPOs

    IBD | Oct. 13, 2014 | 16:33PM EST
  48. Alnylam Drug Scores Against Rare Nerve Disease

    IBD | Oct. 13, 2014 | 13:59PM EST
  49. Merck to release hep C data

    IBD | Oct. 8, 2014 | 18:38PM EST
  50. Merck, Bristol, Arrowhead Prep Hepatitis Studies

    IBD | Oct. 8, 2014 | 13:36PM EST
Trading Center